Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4067685, 7 pages
http://dx.doi.org/10.1155/2016/4067685
Research Article

Positive Expression of Human Cytomegalovirus Phosphoprotein 65 in Atherosclerosis

1Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
2The First Cooperation of Chinese and Western Medicine Hospital of Beijing, Beijing, China

Received 16 May 2016; Revised 7 September 2016; Accepted 19 October 2016

Academic Editor: Eberval G. Figueiredo

Copyright © 2016 Zhe Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Pierdomenico, M. Di Nicola, A. L. Esposito et al., “Prognostic value of different indices of blood pressure variability in hypertensive patients,” American Journal of Hypertension, vol. 22, no. 8, pp. 842–847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Lloyd-Jones, R. Adams, M. Carnethon et al., “Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee,” Circulation, vol. 119, no. 3, pp. 480–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Barquera, A. Pedroza-Tobías, C. Medina et al., “Global overview of the epidemiology of atherosclerotic cardiovascular disease,” Archives of Medical Research, vol. 46, no. 5, pp. 328–338, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. GBD 2013 Mortality and Causes of Death Collaborators and Collaborators listed at the end of the Article, “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 385, no. 9963, pp. 117–171, 2015. View at Publisher · View at Google Scholar
  5. R. B. Singh, S. A. Mengi, Y. J. Xu, A. S. Arneja, and N. S. Dhalla, “Pathogenesis of atherosclerosis: a multifactorial process,” Experimental & Clinical Cardiology, vol. 7, no. 1, pp. 40–53, 2002. View at Google Scholar
  6. F. Domont and P. Cacoub, “Chronic hepatitis C virus infection, a new cardiovascular risk factor?” Liver International, vol. 36, no. 5, pp. 621–627, 2016. View at Publisher · View at Google Scholar
  7. P. Pateria, G. P. Jeffrey, G. MacQuillan et al., “The association between chronic hepatitis C infection and cardiovascular risk,” Internal Medicine Journal, vol. 46, no. 1, pp. 63–70, 2016. View at Publisher · View at Google Scholar
  8. G. P. Thomas, X. Li, W. S. Post et al., “Associations between antiretroviral use and subclinical coronary atherosclerosis,” AIDS, vol. 30, no. 16, pp. 2477–2486, 2016. View at Publisher · View at Google Scholar
  9. M. Krikke, J. Arends, S. Van Lelyveld, A. Hoepelman, and F. Visseren, “Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort,” HIV Medicine, 2016. View at Publisher · View at Google Scholar
  10. J. Zhu, A. A. Quyyumi, J. E. Norman, G. Csako, and S. E. Epstein, “Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels,” Journal of the American College of Cardiology, vol. 34, no. 6, pp. 1738–1743, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Nikitskaya, A. Lebedeva, O. Ivanova et al., “Cytomegalovirus‐productive infection is associated with acute coronary syndrome,” Journal of the American Heart Association, vol. 5, no. 8, Article ID e003759, 2016. View at Publisher · View at Google Scholar
  12. E. J. Plosa, J. C. Esbenshade, M. P. Fuller, and J.-H. Weitkamp, “Cytomegalovirus infection,” Pediatrics in Review, vol. 33, no. 4, pp. 156–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Fang and Y. Ji, “New progresses in human cytomegalovirus latency and reactivation,” Laboratory Medicine, vol. 25, pp. 240–243, 2010. View at Google Scholar
  14. K. Tanaka, J.-P. Zou, K. Takeda et al., “Effects of human cytomegalovirus immediate-early proteins on p53- mediated apoptosis in coronary artery smooth muscle cells,” Circulation, vol. 99, no. 13, pp. 1656–1659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Speir, R. Modali, E.-S. Huang et al., “Potential role of human cytomegalovirus and p53 interaction in coronary restenosis,” Science, vol. 265, no. 5170, pp. 391–394, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. F. Zhou, M. B. Leon, M. A. Waclawiw et al., “Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy,” The New England Journal of Medicine, vol. 335, no. 9, pp. 624–630, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. Nieto, E. Adam, P. Sorlie et al., “Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis,” Circulation, vol. 94, no. 5, pp. 922–927, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Zhang, Y.-Y. Liu, H.-L. Sun et al., “High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients,” Medical Science Monitor, vol. 21, pp. 4102–4110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ansari, M. Makvandi, and A. R. Samarbaf-Zadeh, “Corrigendum to: hepatitis B virus genotyping among patients with cirrhosis [Published in Jundishapur J Microbiol. 2015 March; 8(3): e14571.],” Jundishapur Journal of Microbiology, vol. 8, no. 8, Article ID e29836, 2015. View at Publisher · View at Google Scholar
  20. S. J. Jeong, N. S. Ku, S. H. Han et al., “Anti-cytomegalovirus antibody levels are associated with carotid atherosclerosis and inflammatory cytokine production in elderly Koreans,” Clinica Chimica Acta, vol. 445, pp. 65–69, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Wang, X. Yang, J. Cai, H. Shi, G. Zhong, and H. Chi, “Vascular endothelial function of patients with stable coronary artery disease,” Pakistan Journal of Medical Sciences, vol. 31, no. 3, pp. 538–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. F. P. Martínez, R. Cruz, F. Lu et al., “CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication,” Journal of Virology, vol. 88, no. 13, pp. 7389–7401, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Fu, L. Chen, and M. Luo, “Temporal-spacial characteristics of HCMV protein IE1 and pp65 relation in infected HEL cells,” Practical Preventive Medicine, vol. 3, p. 3, 2006. View at Google Scholar
  24. M. Chevillotte, S. Landwehr, L. Linta et al., “Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages,” Journal of Virology, vol. 83, no. 6, pp. 2480–2490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Chen, W. Li, and L. Zheng, “Detection of human cytomegalovirus phosphoprotein 65 in renal transplant recipients,” Chinese Journal of Health Laboratory Technology, vol. 18, pp. 1585–1586, 2008. View at Google Scholar
  26. X. Lin and Y. Ji, “Progresses in research on human cytomegalovirus pp65,” Journal of Clinical Transfusion and Laboratory Medicine, vol. 8, pp. 74–75, 2006. View at Google Scholar
  27. J. Yang and D. Wang, “Clinical value of human cytomegalovirus phosphoprotein 65 in the diagnosis of cytomegalovirus disease,” Journal of Southern Medical University, vol. 28, no. 2, pp. 263–265, 2008. View at Google Scholar · View at Scopus